Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

Discovery may open the way for new treatments for multiple sclerosis, leukodystrophies OHSU researchers discover a gene that ...

Carmen McCane's motivation is deeply personal. Her mother was diagnosed with MS, and as an avid runner, McCane saw an ...

Multiple sclerosis is the most prevalent chronic inflammatory disease of the central nervous system (CNS), affecting more than 2 million people worldwide (at least 400,000 in the United States), 1 ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

Treatment Options for Multiple Sclerosis. This review focuses on the current knowledge of the pathogenesis of the inflammatory and neurodegenerative elements of the multiple sclerosis plaque. In ...

DelveInsight’s, “Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ ...

Selma Blair reveals multiple sclerosis diagnosis 03:18. Selma Blair revealed this week she was leaving "Dancing with the Stars" due to complications from multiple sclerosis.

Multiple sclerosis (MS) is a chronic disease that affects your brain and spinal cord. When you have it, your immune system -- your body's defense against germs -- attacks the insulation, or myelin ...